Richard Aguilar, Chief Clinical Officer at Cano Health, Inc. (CANO), sold 2,151,880 shares at $1.42 ($2.1M) on 2023-06-12, disclosed to the SEC on 2023-06-13.
Open-market sale of $2.1M CANO by Chief Clinical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.32 | 400,000 | $528K | 25.3% |
| 2 | $0.00 | 600,000 | $0 | 0.0% |
| 3 | $1.29 | 275,940 | $356K | 17.0% |
| 4 | $1.29 | 275,940 | $356K | 17.0% |
| 5 | $1.38 | 100,000 | $138K | 6.6% |
| 6 | $1.42 | 500,000 |
| $710K |
| 34.0% |
| Total | $0.97 avg | 2,151,880 | $2.1M | 100% |
| Filing → |
| CANO | BUY | 2021-09-14 | $266K | — | Filing → |
| CANO | BUY | 2021-09-01 | $21K | — | Filing → |
| CANO | BUY | 2021-08-31 | $10.0M | — | Filing → |